Cargando…
LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression
Drug resistance to platinum limited therapeutic options for oral squamous cell carcinoma (OSCC). In the current study, we investigated the role of lncRNA HOMEOBOX A11 (HOXA11) antisense RNA (HOXA11-AS) in OSCC resistance to cisplatin (CDDP). We used clinical tissues and OSCC cell lines and induced C...
Autores principales: | Wang, Xiaoyan, Li, Hong, Shi, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558628/ https://www.ncbi.nlm.nih.gov/pubmed/31275988 http://dx.doi.org/10.1155/2019/8645153 |
Ejemplares similares
-
LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018) -
lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma
por: Xu, Jianing, et al.
Publicado: (2020) -
LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma
por: Chen, Rui, et al.
Publicado: (2021) -
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
por: Zhao, Xia, et al.
Publicado: (2018) -
LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
por: Xu, Jiapeng, et al.
Publicado: (2020)